These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 19509233

  • 21. Inhibition of platelet-derived growth factor receptor phosphorylation by STI571 (Gleevec) reduces growth and metastasis of human pancreatic carcinoma in an orthotopic nude mouse model.
    Hwang RF, Yokoi K, Bucana CD, Tsan R, Killion JJ, Evans DB, Fidler IJ.
    Clin Cancer Res; 2003 Dec 15; 9(17):6534-44. PubMed ID: 14695158
    [Abstract] [Full Text] [Related]

  • 22. Imatinib mesylate radiosensitizes human glioblastoma cells through inhibition of platelet-derived growth factor receptor.
    Holdhoff M, Kreuzer KA, Appelt C, Scholz R, Na IK, Hildebrandt B, Riess H, Jordan A, Schmidt CA, Van Etten RA, Dörken B, le Coutre P.
    Blood Cells Mol Dis; 2005 Dec 15; 34(2):181-5. PubMed ID: 15727903
    [Abstract] [Full Text] [Related]

  • 23. Expression of c-ABL, c-KIT, and platelet-derived growth factor receptor-beta in ovarian serous carcinoma and normal ovarian surface epithelium.
    Schmandt RE, Broaddus R, Lu KH, Shvartsman H, Thornton A, Malpica A, Sun C, Bodurka DC, Gershenson DM.
    Cancer; 2003 Aug 15; 98(4):758-64. PubMed ID: 12910520
    [Abstract] [Full Text] [Related]

  • 24. [Imatinib].
    Urabe A.
    Gan To Kagaku Ryoho; 2003 Aug 15; 30(8):1191-6. PubMed ID: 12938280
    [Abstract] [Full Text] [Related]

  • 25. The effect of imatinib mesylate (Glivec) on human tumor-derived cells.
    Knight LA, Di Nicolantonio F, Whitehouse PA, Mercer SJ, Sharma S, Glaysher S, Hungerford JL, Hurren J, Lamont A, Cree IA.
    Anticancer Drugs; 2006 Jul 15; 17(6):649-55. PubMed ID: 16917210
    [Abstract] [Full Text] [Related]

  • 26. Cyclooxygenase-2 induction and prostaglandin E2 accumulation in squamous cell carcinoma as a consequence of epidermal growth factor receptor activation by imatinib mesylate.
    Johnson FM, Yang P, Newman RA, Donato NJ.
    J Exp Ther Oncol; 2004 Dec 15; 4(4):317-25. PubMed ID: 15844661
    [Abstract] [Full Text] [Related]

  • 27. [Imatinib and solid tumours].
    Arifi S, El Sayadi H, Dufresne A, Ray-Coquard I, Fayette J, Méeus P, Ranchère D, Decouvelaere AV, Alberti L, Tabone-Eglinger S, Blay JY, Cassier P.
    Bull Cancer; 2008 Jan 15; 95(1):99-106. PubMed ID: 18230575
    [Abstract] [Full Text] [Related]

  • 28. Overexpression of the NF2 gene inhibits schwannoma cell proliferation through promoting PDGFR degradation.
    Fraenzer JT, Pan H, Minimo L, Smith GM, Knauer D, Hung G.
    Int J Oncol; 2003 Dec 15; 23(6):1493-500. PubMed ID: 14612918
    [Abstract] [Full Text] [Related]

  • 29. Inhibition of tyrosine kinases PDGFR and C-Kit by imatinib mesylate interferes with postnatal testicular development in the rat.
    Nurmio M, Toppari J, Zaman F, Andersson AM, Paranko J, Söder O, Jahnukainen K.
    Int J Androl; 2007 Aug 15; 30(4):366-76; discussion 376. PubMed ID: 17705809
    [Abstract] [Full Text] [Related]

  • 30. Platelet-derived growth factor receptor antagonist STI571 (imatinib mesylate) inhibits human vascular smooth muscle proliferation and migration in vitro but not in vivo.
    Hacker TA, Griffin MO, Guttormsen B, Stoker S, Wolff MR.
    J Invasive Cardiol; 2007 Jun 15; 19(6):269-74. PubMed ID: 17541129
    [Abstract] [Full Text] [Related]

  • 31. Imatinib mesylate efficiently achieves therapeutic intratumor concentrations in vivo but has limited activity in a xenograft model of small cell lung cancer.
    Wolff NC, Randle DE, Egorin MJ, Minna JD, Ilaria RL.
    Clin Cancer Res; 2004 May 15; 10(10):3528-34. PubMed ID: 15161712
    [Abstract] [Full Text] [Related]

  • 32. [In vitro killing effects of STI571 on esophageal carcinoma cell lines CE-48T and CE-81T].
    Zhang PY, Li BJ, Su XD, Wen ZS, Zhao JM, Zhang LJ, Long H, Rong TH.
    Ai Zheng; 2006 Apr 15; 25(4):456-60. PubMed ID: 16613680
    [Abstract] [Full Text] [Related]

  • 33. Inhibitory effect of STI571 on cell proliferation of human malignant fibrous histiocytoma cell lines.
    Kawamoto T, Akisue T, Marui T, Nakatani T, Hitora T, Fujita I, Kurosaka M, Yamamoto T.
    Anticancer Res; 2004 Apr 15; 24(5A):2675-9. PubMed ID: 15517872
    [Abstract] [Full Text] [Related]

  • 34. Adult reproductive functions after early postnatal inhibition by imatinib of the two receptor tyrosine kinases, c-kit and PDGFR, in the rat testis.
    Nurmio M, Kallio J, Toppari J, Jahnukainen K.
    Reprod Toxicol; 2008 Aug 15; 25(4):442-6. PubMed ID: 18472395
    [Abstract] [Full Text] [Related]

  • 35. Multicenter Phase II trial of high-dose imatinib mesylate in metastatic melanoma: significant toxicity with no clinical efficacy.
    Wyman K, Atkins MB, Prieto V, Eton O, McDermott DF, Hubbard F, Byrnes C, Sanders K, Sosman JA.
    Cancer; 2006 May 01; 106(9):2005-11. PubMed ID: 16565971
    [Abstract] [Full Text] [Related]

  • 36. Imatinib mesylate (gleevec; STI571) monotherapy is ineffective in suppressing human anaplastic thyroid carcinoma cell growth in vitro.
    Dziba JM, Ain KB.
    J Clin Endocrinol Metab; 2004 May 01; 89(5):2127-35. PubMed ID: 15126530
    [Abstract] [Full Text] [Related]

  • 37. Assessment of antiangiogenic effect of imatinib mesylate on vestibular schwannoma tumors using in vivo corneal angiogenesis assay.
    Yener U, Avsar T, Akgün E, Şeker A, Bayri Y, Kılıç T.
    J Neurosurg; 2012 Oct 01; 117(4):697-704. PubMed ID: 22900848
    [Abstract] [Full Text] [Related]

  • 38. STI571 (Gleevec) improves tumor growth delay and survival in irradiated mouse models of glioblastoma.
    Geng L, Shinohara ET, Kim D, Tan J, Osusky K, Shyr Y, Hallahan DE.
    Int J Radiat Oncol Biol Phys; 2006 Jan 01; 64(1):263-71. PubMed ID: 16274936
    [Abstract] [Full Text] [Related]

  • 39. Growth inhibition of rat osteosarcoma and malignant fibrous histiocytoma cells by tyrosine kinase inhibitor STI571.
    Yoshitani K, Honoki K, Morishita T, Kido A, Miyauchi Y, Mii Y, Takakura Y.
    In Vivo; 2003 Jan 01; 17(3):255-8. PubMed ID: 12929576
    [Abstract] [Full Text] [Related]

  • 40. Expression of c-kit and platelet-derived growth factor receptors in ovarian granulosa cell tumors.
    Rocconi RP, Matthews KS, Kimball KJ, Conner MG, Baker AC, Barnes MN.
    Reprod Sci; 2008 Sep 01; 15(7):673-7. PubMed ID: 18492696
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.